An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

A new American Diabetes Association consensus statement provides guidance on screening, diagnosing, and managing metabolic ...

A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...

Apr. 30, 2025 — Semaglutide effectively treats liver disease in two thirds of patients, new research has ... New Human 'Multi-Zonal' Liver Organoids Improve Injury Survival in Rodents Apr. 16 ...

The Wall Street Journal reports on the expected FDA approval of lenacapavir and what it might mean for Gilead's future in the market. Other coverage of science and research-related news is on a ...

Currently, the only approved treatment for MASH on the market is the thyroid hormone receptor β agonist resmetirom (Rezdiffra ...

Improves fibrosis and steatohepatitis Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a broad clinical spectrum, ranging from simple steatosis to metabolic ...

Among patients who experienced an early cardiovascular event, those treated with semaglutide had approximately 40% fewer ...